Tocqueville Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Sell
106,964
-515
-0.5% -$101K 0.3% 97
2026
Q1
$21.1M Sell
107,479
-1,740
-2% -$338K 0.31% 91
2025
Q4
$19M Sell
109,219
-340
-0.3% -$61.9K 0.28% 101
2025
Q3
$20.9M Sell
109,559
-1,809
-2% -$321K 0.3% 91
2025
Q2
$20M Sell
111,368
-2,485
-2% -$432K 0.3% 97
2025
Q1
$19.3M Sell
113,853
-8,282
-7% -$1.36M 0.31% 92
2024
Q4
$18.4M Sell
122,135
-2,759
-2% -$429K 0.29% 92
2024
Q3
$19.4M Sell
124,894
-860
-0.7% -$128K 0.3% 90
2024
Q2
$17.2M Sell
125,754
-869
-0.7% -$119K 0.28% 93
2024
Q1
$16.9M Sell
126,623
-257
-0.2% -$33.3K 0.28% 100
2023
Q4
$17.5M Sell
126,880
-5,055
-4% -$665K 0.32% 87
2023
Q3
$16.1M Sell
131,935
-192
-0.1% -$25.6K 0.31% 92
2023
Q2
$18.6M Buy
132,127
+252
+0.2% +$34.7K 0.33% 84
2023
Q1
$18.7M Buy
131,875
+331
+0.3% +$47.4K 0.35% 81
2022
Q4
$20.6M Sell
131,544
-313
-0.2% -$45K 0.39% 66
2022
Q3
$16.2M Sell
131,857
-6
-0% -$790 0.33% 85
2022
Q2
$17.5M Sell
131,863
-2,256
-2% -$307K 0.32% 81
2022
Q1
$18.4M Sell
134,119
-844
-0.6% -$118K 0.28% 93
2021
Q4
$23.4M Buy
134,963
+174
+0.1% +$26.5K 0.32% 78
2021
Q3
$19.6M Buy
134,789
+369
+0.3% +$54K 0.29% 92
2021
Q2
$17.7M Sell
134,420
-180
-0.1% -$23.6K 0.26% 104
2021
Q1
$17.3M Sell
134,600
-1,675
-1% -$206K 0.27% 104
2020
Q4
$16.2M Sell
136,275
-210
-0.2% -$25.6K 0.27% 95
2020
Q3
$15.6M Sell
136,485
-240
-0.2% -$28.4K 0.3% 85
2020
Q2
$15.6M Sell
136,725
-780
-0.6% -$82.7K 0.32% 72
2020
Q1
$11M Buy
137,505
+150
+0.1% +$15.5K 0.27% 88
2019
Q4
$14.7M Sell
137,355
-34,080
-20% -$3.55M 0.22% 125
2019
Q3
$18.3M Sell
171,435
-2,441
-1% -$251K 0.25% 117
2019
Q2
$17.7M Sell
173,876
-10,300
-6% -$990K 0.23% 124
2019
Q1
$16.6M Sell
184,176
-10,269
-5% -$890K 0.22% 127
2018
Q4
$16.2M Sell
194,445
-1,815
-0.9% -$170K 0.24% 112
2018
Q3
$21.2M Sell
196,260
-5,100
-3% -$559K 0.27% 110
2018
Q2
$22.1M Sell
201,360
-927
-0.5% -$96.6K 0.28% 108
2018
Q1
$20.3M Buy
202,287
+3,456
+2% +$354K 0.26% 110
2017
Q4
$19.6M Sell
198,831
-2,563
-1% -$243K 0.22% 121
2017
Q3
$18.9M Sell
201,394
-356
-0.2% -$37.8K 0.22% 124
2017
Q2
$22.4M Buy
201,750
+498
+0.2% +$52.7K 0.27% 101
2017
Q1
$19.8M Sell
201,252
-650
-0.3% -$62K 0.24% 118
2016
Q4
$18.6M Buy
201,902
+24,330
+14% +$2.1M 0.24% 124
2016
Q3
$15M Sell
177,572
-44,247
-20% -$3.72M 0.18% 150
2016
Q2
$18.1M Sell
221,819
-3,010
-1% -$229K 0.22% 113
2016
Q1
$16.1M Buy
224,829
+4,870
+2% +$327K 0.21% 128
2015
Q4
$15.6M Buy
219,959
+21,085
+11% +$1.42M 0.21% 135
2015
Q3
$12.2M Buy
198,874
+3,410
+2% +$238K 0.16% 168
2015
Q2
$14.2M Sell
195,464
-9,986
-5% -$737K 0.17% 166
2015
Q1
$15.8M Sell
205,450
-708
-0.3% -$50.7K 0.19% 151
2014
Q4
$13.8M Buy
206,158
+4,300
+2% +$271K 0.15% 172
2014
Q3
$12.2M Sell
201,858
-3,736
-2% -$230K 0.14% 184
2014
Q2
$12.1M Sell
205,594
-207,958
-50% -$12.2M 0.12% 197
2014
Q1
$24M Sell
413,552
-37,334
-8% -$2M 0.32% 99
2013
Q4
$24.1M Buy
450,886
+172,985
+62% +$10.3M 0.32% 94
2013
Q3
$17.2M Buy
277,901
+8,745
+3% +$523K 0.21% 134
2013
Q2
$16.3M Buy
+269,156
New +$16M 0.22% 131

Other funds holding DGX

Tocqueville Asset Management's DGX Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Quest Diagnostics (DGX) stake by 0.48% in Q2 2026, selling an estimated $101K and leaving 106,964 shares worth $22.7M. The position accounts for 0.3% of the portfolio, ranked #97.

Tocqueville Asset Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.1M in Q4 2013. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Tocqueville Asset Management held 106,964 shares of Quest Diagnostics worth $22.7M as of Q2 2026.
  • Tocqueville Asset Management sold 515 Quest Diagnostics shares in Q2 2026, an estimated $101K.
  • Quest Diagnostics made up 0.3% of Tocqueville Asset Management's portfolio in Q2 2026, its #97 holding.
  • Tocqueville Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Tocqueville Asset Management's Quest Diagnostics position peaked at $24.1M in Q4 2013.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.